John Lahart
Question:177. Deputy John Lahart asked the Minister for Health when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if he will make a statement on the matter. [24969/22]
View answer